HPV-T

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHPV-T
Drug Alias Nametumor HPV-E6/E7-targeting T cell suspension (Shenzhen BGI Genomics Technology)HPV-T
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionProtein E6 modulatorsProtein E7 modulators
TargetsProtein E7Protein E6
Therapy Area/IndicationsSolid tumoursPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBgi Shenzhen
China Registration ClassN/A

Develop Information

Active CompaniesBgi Shenzhen
Inactive CompaniesN/A
Active IndicationsSolid tumoursPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A